Clean Science and Technology Ltd (CLEAN) Q3FY26 Management Mirror - Dec-2025 Qtr
Financial Outlook & Margins
Status: Reaffirmed
Management expects the challenging environment (muted offtake, pricing pressure) to persist for at least the next two quarters (Dec'25 Qtr), continuing the cautious tone from Sep'25 Qtr where EBITDA guidance was withheld.
Anticipates immediate margin benefits in downstream products (TBHQ, Veratrole) following the recent commercialization of the hydroquinone/catechol plant.
Maintains the long-term endeavor to return to historical 21-23% growth levels, though current macro headwinds remain a constraint.
Expectations have moderated sequentially: In Jun'25 Qtr, management targeted revenue acceleration by Q3/Q4; by Sep'25 Qtr, Q3 was expected to be flat; now in Dec'25 Qtr, weakness is expected to continue for two more quarters.
3 more themes on the ELITE plan.